Zealand Pharma A/S (LON:0NZU)
London
· Delayed Price · Currency is GBP · Price in DKK 741.75
-39.94 (-5.11%)
At close: Feb 20, 2025
Zealand Pharma Cash Flow Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -1,079 | -703.74 | -1,202 | -1,018 | -846.73 | Upgrade
|
| Depreciation & Amortization | 23.12 | 20.12 | 101.57 | 27.82 | 42.69 | Upgrade
|
| Other Amortization | 16.49 | 1.2 | 1.34 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 4.71 | -0.7 | 6.52 | - | Upgrade
|
| Stock-Based Compensation | 87.03 | 61.43 | 52.29 | 53.5 | 30.49 | Upgrade
|
| Other Operating Activities | -101.01 | 138.51 | 81.67 | -130.47 | -12.98 | Upgrade
|
| Change in Accounts Receivable | -48.96 | -6.76 | 26.64 | -64.49 | -7.72 | Upgrade
|
| Change in Inventory | -2.76 | 9.34 | 18.22 | -52.77 | -14.4 | Upgrade
|
| Change in Accounts Payable | 89.92 | 39.84 | 21.55 | -49.06 | 119.94 | Upgrade
|
| Change in Other Net Operating Assets | 84.19 | 9.68 | -56.25 | - | - | Upgrade
|
| Operating Cash Flow | -930.82 | -425.67 | -942.31 | -1,212 | -688.72 | Upgrade
|
| Capital Expenditures | -10.05 | -11.24 | -11.71 | -22.13 | -25.04 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -167.79 | Upgrade
|
| Sale (Purchase) of Intangibles | -3.1 | -12.51 | - | - | - | Upgrade
|
| Investment in Securities | -7,320 | -1,070 | 186.58 | - | - | Upgrade
|
| Other Investing Activities | - | - | 106.39 | 4.01 | -3.97 | Upgrade
|
| Investing Cash Flow | -7,333 | -1,094 | 281.26 | -18.12 | -196.81 | Upgrade
|
| Long-Term Debt Issued | 369.87 | - | - | 647.91 | - | Upgrade
|
| Long-Term Debt Repaid | -16.44 | -543.43 | -449.81 | -14.72 | -29.22 | Upgrade
|
| Net Debt Issued (Repaid) | 353.43 | -543.43 | -449.81 | 633.19 | -29.22 | Upgrade
|
| Issuance of Common Stock | 8,523 | 1,564 | 1,085 | 775.05 | 832.87 | Upgrade
|
| Repurchase of Common Stock | -351.83 | -41.6 | - | -28.59 | - | Upgrade
|
| Other Financing Activities | -236.58 | -71.91 | -47.35 | -46.9 | -42.71 | Upgrade
|
| Financing Cash Flow | 8,288 | 907.01 | 587.5 | 1,333 | 760.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | 6.23 | -7.24 | 13.68 | 66.22 | 3.74 | Upgrade
|
| Net Cash Flow | 30.99 | -619.92 | -59.87 | 168.88 | -120.84 | Upgrade
|
| Free Cash Flow | -940.87 | -436.91 | -954.02 | -1,234 | -713.76 | Upgrade
|
| Free Cash Flow Margin | -1500.80% | -127.46% | -917.45% | -1136.94% | -371.75% | Upgrade
|
| Free Cash Flow Per Share | -14.16 | -7.72 | -20.65 | -28.79 | -18.60 | Upgrade
|
| Cash Interest Paid | 24.03 | 25.25 | 34.12 | 3.3 | 4.56 | Upgrade
|
| Cash Income Tax Paid | -11.16 | -11.3 | -9.28 | 41.63 | - | Upgrade
|
| Levered Free Cash Flow | -736.41 | -228.98 | -384.08 | -589.73 | -342.47 | Upgrade
|
| Unlevered Free Cash Flow | -728.89 | -213.78 | -349.29 | -587.18 | -311.65 | Upgrade
|
| Change in Net Working Capital | 35.45 | -78.94 | -16.29 | 153.1 | -38.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.